204 related articles for article (PubMed ID: 26530794)
1. Standardization, Evaluation, and Area-Under-Curve Analysis of Human and Murine Treg Suppressive Function.
Akimova T; Levine MH; Beier UH; Hancock WW
Methods Mol Biol; 2016; 1371():43-78. PubMed ID: 26530794
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune Lymphoproliferative Syndrome-FAS Patients Have an Abnormal Regulatory T Cell (Treg) Phenotype but Display Normal Natural Treg-Suppressive Function on T Cell Proliferation.
Mazerolles F; Stolzenberg MC; Pelle O; Picard C; Neven B; Fischer A; Magerus-Chatinet A; Rieux-Laucat F
Front Immunol; 2018; 9():718. PubMed ID: 29686686
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells.
Jaramillo-Ruiz D; De La Mata FJ; Gómez R; Correa-Rocha R; Muñoz-Fernández MÁ
PLoS One; 2016; 11(1):e0145760. PubMed ID: 26785250
[TBL] [Abstract][Full Text] [Related]
5. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
Sahin E; Sahin M
J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
[TBL] [Abstract][Full Text] [Related]
6. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.
Ford McIntyre MS; Gao JF; Li X; Naeini BM; Zhang L
Int Immunopharmacol; 2011 May; 11(5):597-603. PubMed ID: 21109036
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
8. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
9. Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells.
Garg G; Nikolouli E; Hardtke-Wolenski M; Toker A; Ohkura N; Beckstette M; Miyao T; Geffers R; Floess S; Gerdes N; Lutgens E; Osterloh A; Hori S; Sakaguchi S; Jaeckel E; Huehn J
Oncotarget; 2017 May; 8(22):35542-35557. PubMed ID: 28415767
[TBL] [Abstract][Full Text] [Related]
10. Treg functional stability and its responsiveness to the microenvironment.
Barbi J; Pardoll D; Pan F
Immunol Rev; 2014 May; 259(1):115-39. PubMed ID: 24712463
[TBL] [Abstract][Full Text] [Related]
11. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
[TBL] [Abstract][Full Text] [Related]
12. Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets.
Ehx G; Hannon M; Beguin Y; Humblet-Baron S; Baron F
Oncotarget; 2015 Dec; 6(41):43255-66. PubMed ID: 26657728
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells and their roles in immune dysregulation and allergy.
Pellerin L; Jenks JA; Bégin P; Bacchetta R; Nadeau KC
Immunol Res; 2014 May; 58(2-3):358-68. PubMed ID: 24781194
[TBL] [Abstract][Full Text] [Related]
14. Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.
von Knethen A; Heinicke U; Weigert A; Zacharowski K; Brüne B
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235291
[TBL] [Abstract][Full Text] [Related]
15. Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma.
Woods DM; Ramakrishnan R; Laino AS; Berglund A; Walton K; Betts BC; Weber JS
Clin Cancer Res; 2018 Dec; 24(24):6236-6247. PubMed ID: 30131384
[TBL] [Abstract][Full Text] [Related]
16. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from
Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A
Front Immunol; 2018; 9():199. PubMed ID: 29467769
[TBL] [Abstract][Full Text] [Related]
17. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
18. Human CD39
Magid-Bernstein JR; Rohowsky-Kochan CM
J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
[TBL] [Abstract][Full Text] [Related]
19. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
20. In vitro suppression assay for functional assessment of human regulatory T cells.
Tran DQ
Methods Mol Biol; 2013; 979():199-212. PubMed ID: 23397398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
